Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Projected CAGR for the Influenza Diagnostic Market Size from 2025 to 2034?

In the past few years, there has been a consistent growth in the influenza diagnostic market size. It is projected to expand from $2.73 billion in 2024 to $2.87 billion in 2025, with a compound annual growth rate (CAGR) of 4.9%. The unprecedented growth during the historic period is due to factors such as the expansion of e-commerce, labor shortages, increased automation and productivity, optimization of the supply chain, escalating labor costs, and governmental backing for automation and robotics.

The market for influenza diagnostics is predicted to witness significant expansion in the upcoming years. It is estimated to reach a value of$3.9 billion” by 2029, growing at a Compound Annual Growth Rate (CAGR) of 8.0%. This growth, projected for the forecast period, can be linked to factors such as customization and scalability, achieving environmental and sustainability aims, enhancing operational efficiency, and addressing the needs of contemporary supply chain dynamics. The foreseeable future is set to observe major trends such as the incorporation of state-of-the-art technology, robotic assembling and packaging, autonomous mobile robots, live data and analytics, AI-powered decision making, cooperative robots, as well as advancements in the realm of robotic technology.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

What Are the Core Market Drivers Propelling Growth in the Influenza Diagnostic Industry?

The influenza diagnostic market is predicted to grow significantly owing to the increased usage of rapid diagnostic tests. These are medical techniques used to determine or exclude the possibility of a disease or condition. There has been a noteworthy rise in the demand for rapid diagnostic tests owing to their fast, accurate healthcare results. Rapid influenza diagnostic tests, which can identify viral antigens related to influenza in just 10-15 minutes with a moderate sensitivity of 50-70%, are significant contributors. For example, in July 2024, the Australian Institute of Health and Welfare reported that the number of diagnostic imaging services in Australia increased from 28.4 million in 2021-22 to 29.7 million in 2022-23. Consequently, these swift diagnostic tests are fueling the expansion of the influenza diagnostic market.

How Is the Influenza Diagnostic Market Segmented?

The influenza diagnosticmarket covered in this report is segmented –

1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT); Viral Culture; DFA; Serological assays; Other Traditional diagnostic tests

2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR); Isothermal Nucleic Acid Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Other Isothermal Nucleic Acid Amplification Tests; Other Molecular Diagnostic Tests

3) By End User: Hospitals And Clinical Laboratories; Diagnostic Reference Laboratories; Academic/Research Institutes; Other End Users

Subsegments:

1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests; Lateral Flow Assays; Enzyme Immunoassays (EIA)

2) By Viral Culture: Cell Culture; Egg-based Culture

3) By Direct Fluorescent Antibody (DFA) Test: Direct Fluorescent Antibody Staining

4) By Serological Assays: Hemagglutination Inhibition (HI) Assay; Enzyme-Linked Immunosorbent Assay (ELISA); Western Blotting Assay

5) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR); Immunofluorescence Assays

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3237&type=smp

Which Regions Are Driving the Next Phase of the Influenza Diagnostic Market Growth?

North America was the largest region in the influenza diagnostics market in 2024. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Market Trends and Innovations Are Shaping the Future of the Influenza Diagnostic Industry?

Top firms in the influenza diagnostic market, such as Lucira, are revolutionizing the industry by introducing innovative products like the COVID-19 & Flu Home Test. This one-time use, at-home test kit, can deliver results from nasal swab samples collected by the individual in approximately 30 minutes. To provide an example, Pfizer Inc., an American pharmaceutical corporation, gained approval for the Lucira COVID-19 & Flu Home Test in February 2023. This test can identify influenza A and B – typically referred to as the flu – as well as SARS-CoV-2, the virus responsible for COVID-19.

View the full report here:

https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

How Is the Influenza Diagnostic Market Defined and What Are Its Core Parameters?

Influenza diagnostic is the test used to diagnose influenza including viral culture, serology, rapid antigen testing, reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays. Influenza, commonly known as flu, is a contagious illness caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Common symptoms include fever, sore throat, cough, body ache, fatigue, and headache. The market consists of revenues generated by establishments conducting diagnostics tests for influenza virus detection.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3237

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model